As a healthcare company, we regularly work with healthcare professionals. From collaborating on clinical trials providing high quality, balanced information about our medicines and vaccines, in all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first. All over the world.
Interactions with HCPs and prescribers
On 2 October 2018 we announced a series of changes to our policy for how we work with healthcare professionals (HCPs). The purpose of these changes is to improve understanding of new data and clinical experience with our products and increase transparency of payments to HCPs.
Collaborating on clinical trials and research
Healthcare professionals (HCPs) help us identify potential volunteers for clinical trials, administer the investigational medicine or vaccine to patients, and monitor the results. This unique medical insight and knowledge is vital to the development of new treatments.
We acknowledge the importance of increased transparency and of putting the patient at the centre of every decision we take. We remain committed to disclosing the payments we make to HCPs and intend to expand our reporting of payments to individual HCPs.
Find out more
Healthcare providers in Belgium can find specific information on our products available in Belgium by visiting gskpro.com
Physicians are vital to our organisation and our mission of helping people do more, feel better, live longer. We rely on the expertise and insight of doctors and other healthcare professionals to understand patient needs, and help us to develop new treatments that will best address these needs.
Working with healthcare professionals on clinical trials is an essential part of our efforts to develop new medicines and vaccines.
We are making industry leading reforms to our business model. We have already changed how we incentivise our sales professionals.
We are committed to public disclosure of payments we make to healthcare professionals.
BE/COM/0012/15 Oct 2015